Immunocore Holdings (IMCR) Return on Sales [ROS] (2020 - 2026)
Immunocore Holdings (IMCR) recorded Return on Sales [ROS] of -2.58% in Q2 2026, up 12.60 percentage points from -15.18% a year earlier but down 9.41 percentage points from the prior quarter.
Powered by 
Analysis
Immunocore Holdings (IMCR) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
On a TTM basis, Immunocore Holdings' Return on Sales [ROS] came in at -5.24% as of Jun 30, 2026, up 7.80 percentage points year-over-year; for FY2025, it came in at -11.34%, up 11.38 percentage points from FY2024.
- Annual Return on Sales [ROS] has increased for four straight years, with a five-year change of +274.88 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -22.71% in FY2024 (+1.20 pp), -23.91% in FY2023 (+2.73 pp), -26.64% in FY2022 (+483.08 pp) and -509.72% in FY2021 (-223.50 pp).
- Quarterly Return on Sales [ROS] has ranged from -573.82% in Q4 2021 to 14.98% in Q3 2022 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] has increased for nine consecutive quarters, with an average year-over-year change of +10.43 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 537.43 percentage points in Q3 2022, against a drop of 36.79 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 6.82% (Q1 2026), -18.85% (Q4 2025) and -6.92% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Immunocore Holdings | 1.67 Bn | -1.82 Bn | 101.55 Mn | -13.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -13.31% |
| Jun 30, 2026 | -2.58% |
| Mar 31, 2026 | 6.82% |
| Dec 31, 2025 | -18.85% |
| Sep 30, 2025 | -6.92% |
| Jun 30, 2025 | -15.18% |
| Mar 31, 2025 | -3.85% |
| Dec 31, 2024 | -23.14% |
| Sep 30, 2024 | -10.59% |
| Jun 30, 2024 | -21.24% |
| Mar 31, 2024 | -37.57% |
| Dec 31, 2023 | -24.30% |
| Sep 30, 2023 | -21.81% |
| Jun 30, 2023 | -23.02% |
| Mar 31, 2023 | -26.89% |
| Dec 31, 2022 | -46.45% |
| Sep 30, 2022 | 14.98% |
| Jun 30, 2022 | -21.85% |
| Mar 31, 2022 | -73.24% |
| Dec 31, 2021 | -573.82% |
API Access
Immunocore Holdings Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IMCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();